Nasotapp

Nasotapp

Manufacturer:

Community Pharm PCL

Distributor:

Community Pharm PCL
Concise Prescribing Info
Contents
Per tab Brompheniramine maleate 4 mg, phenylephrine HCl 10 mg. Per 5 mL Brompheniramine maleate 2 mg, phenylephrine HCl 5 mg
Indications/Uses
Symptomatic relief of allergic manifestation of resp illness. Temporary relief of nasal congestion.
Dosage/Direction for Use
Tab Adult & childn ≥12 yr 1 tab tid-qid or 6-8 hrly. Syr Adult & childn >12 yr 10 mL. Childn 6-12 yr 5 mL, 2-6 yr 2.5 mL, <2 yr 1.25 mL. To be taken tid-qid.
Administration
May be taken with or without food.
Contraindications
Hyperthyroidism, HTN & cardiac disease.
Special Precautions
Glaucoma, cardiac disease, diabetes. May affect ability to drive or operate machinery.
Adverse Reactions
Drowsiness, palpitations.
Drug Interactions
MAOIs, CNS depressants, anticholinergics & TCA.
ATC Classification
R01BA53 - phenylephrine, combinations ; Belongs to the class of systemic sympathomimetic preparations used as nasal decongestants.
Presentation/Packing
Form
Nasotapp FC tab
Packing/Price
10 × 10's;50 × 10's
Form
Nasotapp syr
Packing/Price
60 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in